Pulmonary Hypertension - Abstract Session 1

Thursday, 25 June 2009 09:00 - 10:30, Meeting Room 3

Co-Chair Dr Robert Weintraub The Royal Children's HopsitalAustralia
Protecting the lung and the heart in experimental acute lung injury: Low tidal voulme ventilation in combination with intravenous ET-1 receptor blockade by tezosentan
  • Ralf Geiger, Pediatric Cardiology and Pulmonology, Medical University Innsbruck, Austria, Austria
Right ventricular pressure during exercise in adolescents with atrial or ventricular septal defect
  • Mr Thomas Möller, Pediatric Department, Vestfold Hospital Trust, Norway
Role of caveolin-1 in pulmonary hypertension
  • Dr Rajamma Mathew, New York Medical College, United States
Does Anticoagulation in Eisenmenger Syndrome Alter Long-Term Survival?
  • Craig S Broberg, Oregon Health and Science University, United States
Vasoreactivity test in pulmonary arterial hypertension due to congenital heart disease (Eisenmenger syndrome): significance and impact on long term prognosis
  • Michele D'Alto, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
  • Paola Argiento, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
  • Emanuele Romeo, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
  • Giuliano D'Alterio, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
  • Berardo Sarubbi, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
  • Giuseppe Santoro, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
  • Dr Maria Giovanna Russo, Italy
  • Raffaele Calabrò, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
Bosentan Promotes Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells but Inhibits Infiltration of Macrophages into Pulmonary Vascular Lesions in Mice: A New Mechanism of Bosentan in Inhibiting Pulmonary Hypertension
  • Dr Yoshihide Mitani, Mie University Graduate School of Medicine, Japan